Figure 1From: 18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin) Qualitative response assessment. Maximum intensity projection images at 0 and 12 weeks in two subjects, subject A and subject B, showing no significant qualitative change.Back to article page
